Saberwal et al., 2002 - Google Patents
Estrogen receptor, calcium mobilization and rat sperm motilitySaberwal et al., 2002
- Document ID
- 14636083259298298948
- Author
- Saberwal G
- Sharma M
- Balasinor N
- Choudhary J
- Juneja H
- Publication year
- Publication venue
- Molecular and cellular biochemistry
External Links
Snippet
Abstract Oral treatment with 0.4 mg/kg/day of tamoxifen citrate, an antiestrogen, has been reported to reduce the fertility of adult male rat, presumably through estrogen receptors expressed throughout the male reproductive tract. During the course of these studies …
- 241000700159 Rattus 0 title abstract description 49
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lemoine et al. | Estrogen receptor alpha mRNA in human skeletal muscles | |
Durkee et al. | Identification of estrogen receptor protein and messenger ribonucleic acid in human spermatozoa | |
Saberwal et al. | Estrogen receptor, calcium mobilization and rat sperm motility | |
Kraupp et al. | In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note | |
US7015315B1 (en) | Gapped oligonucleotides | |
JP3131222B2 (en) | 2 'modified oligonucleotide having a gap | |
JPH11506914A (en) | Optimized minizymes and miniribozymes and uses thereof | |
Brach et al. | The mitogenic response to tumor necrosis factor alpha requires c-Jun/AP-1 | |
Pathak et al. | Effect of tamoxifen treatment on global and insulin-like growth factor 2-H19 locus-specific DNA methylation in rat spermatozoa and its association with embryo loss | |
Panahian et al. | Enhanced neuronal expression of the oxidoreductase—biliverdin reductase—after permanent focal cerebral ischemia | |
Engstrøm et al. | Effect of pregnancy on rat myometrial β2-adrenoceptor mRNA and isoproterenol-induced relaxation of isolated uterine strips | |
Redmond Jr et al. | Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma dopamine-beta-hydroxylase (DBH) activities in the rhesus monkey | |
Crowley et al. | A chiasma–hormonal hypothesis relating Down's syndrome and maternal age | |
Dolan et al. | Effect of O 6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl (methylsulfonyl) methanesulfonate | |
DAUSSE et al. | Patterns of messenger RNA expression for alpha1-adrenoceptor subtypes in human corpus cavernosum | |
US5856099A (en) | Antisense compositions and methods for modulating type I interleukin-1 receptor expression | |
Kim et al. | Estrogen receptor beta gene+ 1730 G/A polymorphism in women with polycystic ovary syndrome | |
Kaya et al. | Expression of GnRH receptor in the canine corpus luteum, and luteal function following deslorelin acetate‐induced puberty delay | |
WO2008140713A1 (en) | Methods and products for treating proliferative disorders | |
Li et al. | Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells | |
Wang et al. | Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs) | |
WO2001074136A2 (en) | Telomerase inhibitor polynucleotides | |
Spencer et al. | Temporal relationships among uterine pituitary adenylate cyclase-activating polypeptide, decidual prolactin-related protein and progesterone receptor mRNAs expressions during decidualization and gestation in rats | |
Fuchs et al. | Anti-androgenic therapy in young patients and its impact on intensity of hirsutism, acne, menstrual pain intensity and sexuality—a preliminary study | |
Conde-Pérezprina et al. | Msh2 promoter region hypermethylation as a marker of aging-related deterioration in old retired female breeder mice |